EA
HCAT icon

Emerald Advisers’s Health Catalyst HCAT Stock Holding History

Emerald Advisers’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-19,628
Closed -$681K – 260
2019
Q4 		$681K Sell
19,628
-300
-2% -$9.93K 0.03% 167
2019
Q3 		$631K Buy
+19,928
New +$784K 0.03% 170

Other funds holding HCAT

SUT
SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return
NVPX
Norwest Venture Partners XI Palo Alto, California $32.1M AUM 15.68% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Emerald Advisers's HCAT Position: Q1 2020 in Review

Emerald Advisers sold out of Health Catalyst (HCAT) in Q1 2020, closing a stake of 19,628 shares — an estimated $681K sold.

Emerald Advisers first reported a position in HCAT in Q3 2019 and held it in 2 quarters. The position peaked at $681K in Q4 2019. 108 funds tracked by Wall St. Rank hold HCAT as of Q1 2020.

  • Emerald Advisers reported no remaining Health Catalyst position as of Q1 2020 after selling out during the quarter.
  • Emerald Advisers sold 19,628 Health Catalyst shares in Q1 2020, an estimated $681K.
  • Emerald Advisers first reported a position in Health Catalyst in Q3 2019 and held it in 2 quarters.
  • Emerald Advisers's Health Catalyst position peaked at $681K in Q4 2019.
  • 108 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2020.

Based on Emerald Advisers's 13F filing for Q1 2020, filed 30 Apr 2020.